Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats

Authors:
  • KUKenji Uehara
    Kenji Uehara
  • TSToshiki Sudo
    Toshiki Sudo
  • KMKeiko Marukawa
    Keiko Marukawa
  • YYYoshinobu Yasuda
    Yoshinobu Yasuda
  • YKYukio Kimura
    Yukio Kimura

Abstract
No abstract available

This publication has 29 references indexed in Scilit: